RxDoctor Payments Data

Susan Laux

Psychiatric/Mental Health · Oshkosh, WINPI 1750618997

Payments from drug & device makers

$655in general payments, 2019–2025

Across 31 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$246
  • AbbVie$131
  • Teva Pharmaceuticals USA, Inc.$111
  • Indivior Inc.$49
  • Neurocrine Biosciences, Inc.$43
  • Otsuka America Pharmaceutical, Inc.$21
  • plus $53 from 3 others

What the payments were for

  • Food & beverage$54483%
  • Education$11117%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$655 in reported general payments places this provider in the 60th percentile of 384 psychiatric/mental health providers in Wisconsin.

See all psychiatric/mental health providers in Wisconsin

Medicare billing

Part B allowed, 2024
$8,211
Medicare patients
35
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate70$221,419
AristadaAripiprazole Lauroxil61$141,760
IngrezzaValbenazine Tosylate12$104,954
Abilify MaintenaAripiprazole25$72,563
VraylarCariprazine Hcl28$43,749
LybalviOlanzapine/Samidorphan Malate22$34,086
TrintellixVortioxetine Hydrobromide37$17,888
Paliperidone ErPaliperidone21$8,832
Clozapine49$6,581
Quetiapine Fumarate237$3,743
Haloperidol62$2,887
Aripiprazole92$2,869
Benztropine Mesylate137$1,944
Risperidone82$1,667
Divalproex Sodium53$1,658

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada, Lybalvi$246$175,84683 claims
Neurocrine Biosciences, Inc.Ingrezza$43$104,95412 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$21$72,56325 claims
AbbVieVraylar$131$43,74928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 384 psychiatric/mental health providers in Wisconsin.

Other psychiatric/mental health in Oshkosh

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →